Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

MedscapeLIVE! to Host “Neurology Exchange” Virtual Conference

Leading Neurology Faculty to Present Clinical Updates and Management Strategies for Key Neurological Conditions

Medscape Education

Biotech Innovation in the Time of COVID-19

Chris Garabedian, CEO of Xontogeny, dives into biotech and digital health innovation, current industry gaps and obstacles, how to encourage biotech entrepreneurs, AI & machine learning, and much more!

Impetus Digital

- PMLiVE

Breaking Internal Silos to Ensure Patient Centricity is a Key Focus Company-Wide

Mark and Urs will be discussing the pros and cons of an enterprise-wide approach to patient centricity, and explore the measurable benefits it could deliver. • Who should be involved...

- PMLiVE

Geoff Thorne joins FH as Chief Technology Officer to drive innovation for clients

The experienced executive will expand our cross-functional omnichannel, data and analytics, and technology offerings, developing effective solutions to meet our clients’ evolving needs.

Avalere Health

- PMLiVE

NICE rejects AstraZeneca and MSD’s Lynparza as NHS prostate cancer treatment

The drug will not be available as a treatment option for men with prostate cancer in England and Wales

- PMLiVE

NHS to move ahead with Pfizer/BioNTech bivalent COVID-19 vaccine roll-out

The autumn booster programme launches today

New syndicated patient reports –

Living with Uterine Fibroids and Endometriosis US 2022

Inizio

Steve Chick OPEN Health

Steve Chick joins OPEN Health as Chief Growth Officer for Evidence & Access

OPEN Health is pleased to announce the appointment of Stephen J. Chick as Chief Growth Officer for OPEN Health Evidence & Access.

OPEN Health

- PMLiVE

Medscape: Education that delivers skin in the game #EADVCongress

Medscape Education Global to Present Symposia and Posters at the European Academy of Dermatology and Venereology 2022 (EADV)

Medscape Education

- PMLiVE

Bristol Myers Squibb’s acute myeloid leukaemia oral maintenance therapy recommended by NICE

Phase 3 trial results show Onureg offers significantly longer overall and relapse-free survival

- PMLiVE

Sanofi and Regeneron share positive data for asthma drug

The trial evaluated the drug for children aged six to 11 years with moderate-to-severe asthma

The Sofa Sessions – Fourth Page

Page & Page Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links